// App-Quantinova.ai

140 : Dabigatran Is Associated with a Significantly Lower Risk of Abnormal Uterine Bleeding Than Warfarin in Female Patients of Childbearing Age with Venous Thromboembolism

Researchers

Presenter

  • Frederikus A Klok

Principal Investigators

  • Martin Feuring

  • Mandy Fraessdorf

  • Jorg Kreuzer

Medical Centers

  • Thrombosis and Haemostasis, Leiden UniversityMedical Center, Leiden, Netherlands

  • Hospital Garcia de Orta, Almada, Portugal

Locations

  • Portugal

  • Netherlands

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Pradax

  • Hydroxyzine

  • Warfarin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved